22369-96-6 Usage
Description
4-Bromo-2,3-dimethyl acetanilide, also known as 4-bromo-2,3-dimethyl-N-phenylacetamide, is a chemical compound that belongs to the class of acetanilide derivatives. It is a white to off-white crystalline powder with a molecular formula of C10H12BrNO and a molecular weight of 243.11 g/mol. This chemical is widely used in the pharmaceutical industry as an intermediate for the synthesis of various pharmaceutical compounds, as well as a reagent in organic synthesis and a building block for the preparation of other organic compounds. Its properties and applications make it an important chemical in the field of medicinal and synthetic chemistry.
Uses
Used in Pharmaceutical Industry:
4-Bromo-2,3-dimethyl acetanilide is used as an intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and properties make it a valuable component in the development of new drugs and medications.
Used in Organic Synthesis:
As a reagent in organic synthesis, 4-bromo-2,3-dimethyl acetanilide is utilized in various chemical reactions to produce a range of organic compounds. Its versatility and reactivity contribute to its importance in the field of synthetic chemistry.
Used in Preparation of Other Organic Compounds:
4-Bromo-2,3-dimethyl acetanilide also serves as a building block for the preparation of other organic compounds. Its structural features allow it to be incorporated into more complex molecules, further expanding its applications in the realm of chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 22369-96-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,3,6 and 9 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 22369-96:
(7*2)+(6*2)+(5*3)+(4*6)+(3*9)+(2*9)+(1*6)=116
116 % 10 = 6
So 22369-96-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H12BrNO/c1-6-7(2)10(12-8(3)13)5-4-9(6)11/h4-5H,1-3H3,(H,12,13)
22369-96-6Relevant articles and documents
Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulators
Hamann, Lawrence G.,Manfredi, Mark C.,Sun, Chongqing,Krystek Jr., Stanley R.,Huang, Yanting,Bi, Yingzhi,Augeri, David J.,Wang, Tammy,Zou, Yan,Betebenner, David. A.,Fura, Aberra,Seethala, Ramakrishna,Golla, Rajasree,Kuhns, Joyce E.,Lupisella, John A.,Darienzo, Celia J.,Custer, Laura L.,Price, Jennifer L.,Johnson, James M.,Biller, Scott A.,Zahler, Robert,Ostrowski, Jacek
, p. 1860 - 1864 (2008/02/04)
Pharmacokinetic studies in cynomolgus monkeys with a novel prototype selective androgen receptor modulator revealed trace amounts of an aniline fragment released through hydrolytic metabolism. This aniline fragment was determined to be mutagenic in an Ames assay. Subsequent concurrent optimization for target activity and avoidance of mutagenicity led to the identification of a pharmacologically superior clinical candidate without mutagenic potential.
Aniline intermediates
-
, (2008/06/13)
There are provided novel substituted aniline intermediates, useful in the synthesis of certain substituted N-nitroanilines or salts thereof which may be used to elicit several desirable and advantageous biological responses in plants.
